This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: University of California. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023
Title: Innovations in Cancer Immunotherapy by Matthew Spitzer
Introduction
Matthew Spitzer is an accomplished inventor based in San Francisco, CA. He has made significant contributions to the field of cancer immunotherapy. His work focuses on identifying and treating patient populations that are amenable to innovative cancer treatments.
Latest Patents
Matthew Spitzer holds a patent for "Methods of identifying and treating patient populations amenable to cancer immunotherapy." This patent outlines methods for identifying cancer patients who can benefit from anti-cancer immunotherapy. It also includes techniques for monitoring the effectiveness of cancer therapy. The methods involve determining the levels of CD127 low PD-1 low T cells in patients. Those identified as suitable are treated with immune checkpoint inhibitors, such as anti-CTLA-4 antibodies like ipilimumab.
Career Highlights
Matthew Spitzer is affiliated with the University of California, where he conducts research and develops innovative solutions in cancer treatment. His work has the potential to improve patient outcomes significantly.
Collaborations
One of his notable collaborators is Lawrence Fong, who shares a commitment to advancing cancer immunotherapy.
Conclusion
Matthew Spitzer's contributions to cancer immunotherapy through his innovative patent demonstrate his dedication to improving treatment options for patients. His work continues to pave the way for advancements in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile